MeVis Medical Solutions AG / Key word(s): Change in Forecast 22.04.2015 12:34 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bremen, April 22, 2015 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the sale of treasury shares: - For the end of 2015 another increase in liquidity is expected to now EUR 22.0 to 23.0 m mainly due to the additional liquidity from yesterday's completed sale of treasury shares (previous forecast: EUR 20.0 to 21.0 m). - For 2015 revenues are expected to remain stable at between EUR 13.0 and 13.5 m (as in the previous forecast). - For the EBIT (earnings before interest and taxes), a decrease over the previous year to EUR 2.0 to 2.5 million continues to be expected (as in the previous forecast). 22.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone: +49 421 224 95 0 Fax: +49 421 224 95 999 E-mail: [email protected] Internet: http://www.mevis.de ISIN: DE000A0LBFE4 WKN: A0LBFE Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------